OS was observed in 13.5% of sarcoidosis patients, usually at the onset of the disease. It was associated with systemic disease activity persisting for more than 5 years and with central nervous system sarcoidosis.
García-García et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: